Search

In this free webinar, the featured speakers will discuss the primary role of imaging in acute ischemic stroke and the appropriate time points and modalities needed to determine the safety [...]

Phase 3 VOYAGER PAD is the first investigational study in 20 years to highlight the benefit of long-term treatment in these high-risk patients Data add to growing body of evidence [...]

LEUVEN, Belgium and BOSTON, Feb. 23, 2021 /PRNewswire/ -- icometrix , world leader in imaging AI solutions for people with neurological conditions, announced the addition of icobrain cva , a [...]

In this free webinar, the featured speakers will discuss the history of recanalization strategies and current treatment guidelines as well as recent research examining the utility of pharmacological interventions. Attendees [...]

WILLOWBROOK, Ill., Nov. 23, 2019 /PRNewswire/ -- Pharmazz, Inc., a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat patients in critical care, today announced the [...]

Study to investigate whether adipose-derived SVF therapy can reduce amputation, speed up wound healing and increase ambulatory function. HOUSTON, March 26, 2019 /PRNewswire/ -- Tissue Genesis, LLC, the leading provider [...]

- itMSCs were safe and well tolerated in the study - - Results of the study are supportive of advancing clinical program - - Plans are underway to conduct Phase [...]

CERENOVUS Launches Next Generation Stent Retriever at Society of NeuroInterventional Surgery (SNIS) Annual Meeting SAN FRANCISCO, July 24, 2018 /PRNewswire/ -- CERENOVUS, part of the Johnson & Johnson Medical Devices [...]

The post marketing registry will assess the real-life safety and performance of the TIGERTRIEVER revascularization device YOKNEAM, Israel, September 19, 2017 /PRNewswire/ -- Today, http://www.rapid-medical.com/ , a company focused on [...]

WARSAW, Ind., Nov. 15, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced an update on its Investigational Device Exemption [...]

SAN DIEGO, July 11, 2016 /PRNewswire/ -- Angionetics Inc., a wholly-owned subsidiary of Taxus Cardium Pharmaceuticals Group Inc. (Trading Symbol: CRXM), today announced that, an entity affiliated with Huapont Life [...]

SAN DIEGO, June 1, 2016 /PRNewswire/ -- Biotech Holdings announced today positive preclinical results utilizing its ProCell Therapy Protocol on the treatment of ischemic muscular disease. ProCell was effective at [...]

TIJUANA, Mexico, Dec. 24, 2014 /PRNewswire/ -- Novastem, a leader in regenerative medicine, announces the treatment of its first patient in its study for ischemic stroke at Clinica Santa Clarita. [...]

PLYMOUTH, Mass., Nov. 19, 2012 /PRNewswire/ -- Harvest Technologies, a leader in advancing cellular therapies, is pleased to announce CE Marking for an expanded clinical indication for its SmartPReP[sup.] 2 [...]

Development of Novel Neuroprotective and Neurorestorative Therapies Continues to Advance, According to New Findings from Decision Resources WALTHAM, Mass., Feb. 18 /PRNewswire/ -- Decision Resources, one of the world's leading [...]

Randomized, Multi-Center Trial Underway to Evaluate Safety and Efficacy of NeuroFlo Intervention up to 10 hours After Stroke Onset MINNEAPOLIS, Nov. 1 /PRNewswire/ -- CoAxia, Inc. of Maple Grove, MN, [...]